Literature DB >> 20551630

Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours.

Marie Bodenant1, Didier Leys, Stéphanie Debette, Charlotte Cordonnier, Frédéric Dumont, Hilde Hénon, Marie Girot, Christian Lucas, David Devos, Luc Defebvre, Dominique Deplanque, Xavier Leclerc, Régis Bordet.   

Abstract

BACKGROUND: Stroke outcomes are worse in patients admitted at nonworking hours (NWH), but whether this is also true in patients treated with intravenous (i.v.) thrombolysis has not been definitely proven.
OBJECTIVE: Our aim was to test the hypothesis that stroke patients treated by i.v. rt-PA at NWH have a worse outcome than those treated at working hours (WH).
METHODS: We compared outcomes at 7 days and at 3 months, between patients treated at NWH and at WH in the stroke unit of the Lille University Hospital.
RESULTS: Of 252 consecutive patients [median age: 69 years; 132 men (52.4%); median National Institutes of Health Stroke Scale score: 14; median onset-to-needle time: 150 min], 134 (53.2%) were treated at NWH. They did not differ for baseline characteristics and proportion of patients with modified Rankin Scale scores 0-1 and 0-2 at 3 months. Patients treated at WH were more likely to die before 7 days (12.7 vs. 4.5%; adjusted odds ratio: 3.6; 95% confidence interval: 1.2-10.4) and at 3 months (21.6 vs. 11.4%; adjusted odds ratio: 2.2; 95% confidence interval: 1.02-4.7). The causes of death did not differ between NWH and WH. At NWH, there was no difference in baseline characteristics and outcomes of patients treated by stroke- and nonstroke neurologists.
CONCLUSION: The case fatality rates were unexpectedly higher at WH than at NWH. If this finding can be reproduced and is not a chance finding, we should identify explanations, especially organisational issues, chronobiological factors or summation of subtle--nonsignificant--baseline differences. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20551630     DOI: 10.1159/000316058

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  12 in total

1.  Intravenous thrombolysis for acute cerebral ischaemia in old stroke patients ≥ 80 years of age.

Authors:  Gregoire Boulouis; Frederic Dumont; Charlotte Cordonnier; Marie Bodenant; Didier Leys; Hilde Hénon
Journal:  J Neurol       Date:  2011-12-20       Impact factor: 4.849

2.  Influence of glycaemic control on the outcomes of patients treated by intravenous thrombolysis for cerebral ischaemia.

Authors:  Rachel Litke; Solène Moulin; Charlotte Cordonnier; Pierre Fontaine; Didier Leys
Journal:  J Neurol       Date:  2015-08-15       Impact factor: 4.849

3.  Rate of intravenous thrombolysis for acute ischaemic stroke in the North-of-France region and evolution over time.

Authors:  N Dequatre-Ponchelle; H Touzani; A Banh; I Girard-Buttaz; R Coche; P Dobbelaere; C Cordonnier; M Girot; P Aguettaz; F Mounier-Vehier; E Wiel; N Bronet; E Josien; P Duhamel; M Mihout; A Maisonneuve; A Mackowiak; M Bodenant; P Williatte; X Leclerc; C Lefebvre; O Nigeon; P Devos; G Duncan; G Malanda; B Majed; O Dereeper; V Pégoraro; T Rosolacci; P Alarcon; E Koral; M Pasquini; S Verclytte; J B N'Kuendjo; J B Campagne; P Le Coz; J Devienne; Z Seth; R Tholliez; H Hénon; G Smith; F Dumont; F Agbemebia; J M Behra; D Pollet; P Coffin; P Lavau; A Vérier; C Lucas; N Smaiti; P Dalinval; J Dallongeville; P Valette; J P Pruvo; P Goldstein; D Leys
Journal:  J Neurol       Date:  2014-04-22       Impact factor: 4.849

4.  Intra-hospital delays in stroke patients treated with rt-PA: impact of preadmission notification.

Authors:  Barbara Casolla; Marie Bodenant; Marie Girot; Charlotte Cordonnier; Jean-Pierre Pruvo; Eric Wiel; Didier Leys; Patrick Goldstein
Journal:  J Neurol       Date:  2012-10-10       Impact factor: 4.849

5.  Influence of neurologists' experience on the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia.

Authors:  Amélie Tuffal; Solène Moulin; Nelly Dequatre-Ponchelle; Marie Bodenant; Frédéric Dumont; Catherine Lefebvre; Hilde Hénon; Stéphanie Debette; Charlotte Cordonnier; Didier Leys
Journal:  J Neurol       Date:  2015-03-06       Impact factor: 4.849

6.  Mortality in patients treated by intra-venous thrombolysis for ischaemic stroke.

Authors:  Loubna Majhadi; Didier Leys; Marie Bodenant; Hilde Hénon; Régis Bordet; Charlotte Cordonnier
Journal:  J Neurol       Date:  2013-02-07       Impact factor: 4.849

Review 7.  Role of social factors on cell death, cerebral plasticity and recovery after stroke.

Authors:  Venugopal Reddy Venna; Louise D McCullough
Journal:  Metab Brain Dis       Date:  2014-04-22       Impact factor: 3.584

8.  Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes.

Authors:  Ilaria Maestrini; Daniel Strbian; Sophie Gautier; Elena Haapaniemi; Solène Moulin; Tiina Sairanen; Nelly Dequatre-Ponchelle; Gerli Sibolt; Charlotte Cordonnier; Susanna Melkas; Didier Leys; Turgut Tatlisumak; Régis Bordet
Journal:  Neurology       Date:  2015-09-11       Impact factor: 9.910

9.  Outcome of patients with atrial fibrillation after intravenous thrombolysis for cerebral ischaemia.

Authors:  Visnja Padjen; Marie Bodenant; Dejana R Jovanovic; Nelly Ponchelle-Dequatre; Novak Novakovic; Charlotte Cordonnier; Ljiljana Beslac-Bumbasirevic; Didier Leys
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

10.  Baseline serum glucose concentration and symptomatic haemorrhagic transformation in non-diabetic stroke patients treated by intravenous thrombolysis.

Authors:  Mayi Gnofam; Didier Leys; Nelly Ponchelle-Dequatre; Marie Bodenant; Hilde Hénon; Régis Bordet; Charlotte Cordonnier
Journal:  J Neurol       Date:  2013-08-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.